Stock Events

Stock Events

Ligand Pharmaceuticals (LGND) Q2 2026 Earnings

7MayConfirmed

Q2 2025

Q3 2025

Q4 2025

Q2 2026

1.21

1.84

2.46

3.09

Details

Expected EPS

1.815714

Actual EPS

1.63

Surprise EPS

-0.19

Surprise Percent

+10.23%

Description

Ligand Pharmaceuticals (LGND) has reported earnings of 1.63 per share for Q2 2026.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.